Application

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97696561

Filing Date: 11/29/2022

To the Commissioner for Trademarks:

MARK: Restrata MiniMatrix (Standard Characters, see mark)
The literal element of the mark consists of Restrata MiniMatrix. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Acera Surgical, Inc., a corporation of Missouri, having an address of
      Ste 120
      1650 Des Peres Rd.
      St. Louis, Missouri 63131
      United States
      858-707-4203(phone)
      9497609502(fax)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Natural biomaterials for soft tissue repair; natural biomaterials for augmentation of bone or soft tissue for medical purposes.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 010:  Artificial biomaterials for soft tissue repair; particulate product made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; particulate form product made of artificial electrospun biomaterial for use in soft tissue repair or the reconstruction of soft tissue deficiencies; medical devices and apparatuses, namely, particulate form products made of artificial biomaterial for use in repair of soft tissue; artificial biomaterials for augmentation of bone or soft tissue for medical purposes; wound packing product comprising natural, non-living materials.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Kenneth Wang. Other appointed attorneys are John B. Sganga, Jr., Edward A. Schlatter, Gerard von Hoffmann, Joseph R. Re, Catherine J. Holland, John M. Carson, Karen Vogel Weil, Jeffrey L. Van Hoosear, Daniel E. Altman, Lynda J. Zadra-Symes, William H. Shreve, Stephen C. Jensen, Steven J. Nataupsky, Paul A. Stewart, Joseph F. Jennings, Craig S. Summers, Diane M. Reed, Ronald J. Schoenbaum, John R. King, Adeel S. Akhtar, David N. Weiss, Douglas G. Muehlhauser, Lori Lee Yamato, Michael K. Friedland, Stacey R. Halpern, Mark M. Abumeri, Jon W. Gurka, Joseph M. Reisman, Michael L. Fuller, Mark R. Benedict, Paul N. Conover, Robert J. Roby, Sabing H. Lee, Karoline A. Delaney, Joseph S. Cianfrani, William R. Zimmerman, Eric S. Furman, Susan M. Natland, Rose M. Thiessen, Michael A. Guiliana, Rabinder N. Narula, Bruce S. Itchkawitz, John M. Grover, Irfan A. Lateef, Amy Christensen Chun, Mark J. Gallagher, David G. Jankowski, Brian C. Horne, Payson LeMeilleur, Sheila N. Swaroop, Benjamin A. Katzenellenbogen, Andrew N. Merickel, Thomas P. Krzeminski, Linda H. Liu, James F. Herkenhoff, Andrew M. Douglas, Salima A. Merani, Jonathan A. Hyman, Curtiss C. Dosier, Joseph J. Mallon, Sean M. Murray, Christy G. Lea, Perry D. Oldham, Russell M. Jeide, Zi Y. Wong, Matthew S. Bellinger, Mincheol Kim, Gregory A. Hermanson, Lauren Keller Katzenellenbogen, Ted M. Cannon, Carol Pitzel Cruz, Josué A. Villalta, Andrew I. Kimmel, Brenden Gingrich, Maria Culic Anderson, Melanie J. Seelig, Mauricio A. Uribe, Curtis R. Huffmire, Christopher L. Ross, Eli A. Loots, Ryan E. Melnick, Yanna S. Bouris, Philip M. Nelson, Marko R. Zoretic, Kerry S. Taylor, Derek C. Dailey, Jarom D. Kesler, Steven P. Ruden, Colin B. Heideman, Theodore G. Papagiannis, Nicholas M. Zovko, Adam J. Gilbert, Kimberly J. Miller, Bryan W. Wahl, Thomas Y. Yee, Matthaei, Vladimir S. Lozan, Paul S. Stellman, Heungsoo Choi, Nicole Rossi Townes, Vikas Bhargava, Daniel J. Fischer, Jeremy A. Anapol, Scott A. Cromar, Kendall M. Loebbaka, David R. Schmidt, Harnik Shukla, Charlene A. Azema, Morgan R. Coates, Jessica L. Achtsam, Jonathan A. Menkes, Rosaleen H. Chou, Deborah S. Shepherd, Alejandro D. Muñoz, Mark D. Marsden, Joan Y. Chan, Loni L. Morrow, Kyu S. Min, Chang Sik Lim, Thomas S.H. Cowan, Devanie A. DuFour, Alexander J. Martinez, Hans L. Mayer, Jessica C. Sganga, Nicholas A. Belair, Ryan S. Furtado, Angela K. Dremann, Justin J. Gillett, M. Scott Forbes, Brian M. Graham, Brian J. Flynn, Mitchell B. Hadley, Qi Peter Tong, Elenore Niu, Michael P. Burns, David M. Cohen, Mark E. Davis, Jordan Gottdank, Kim A. Kennedy, Daniel C. Kiang, Keith M. Lim, Ashley C. Morales, Nathan D. Reeves, Brandon G. Smith, Xiaoyan Sabrina Wang, April K. White, Jordan M. Cox, Albert J. Sueiras, Mark Rubinshtein, David J. Grant, Clayton R. Henson, Daniel A. Kamkar, Lesley Y. Kim, Nathan J. Lee, Josepher Li, Jacob R. Rosenbaum, James F. Smith, Douglas B. Wentzel, Aryeh N. Feinstein, Noorean I. Gill, Shuchen Gong, Peter A. Hecker, Aaron S. Johnson, Bryan J. Johnson, David C. Kellogg, Chanell Khosrowabadi, Lindsay A. Laddaran, Forrest M. McClellen, Janet M. Allendorph, Alexander Zeng, Sean S. Kim, Benjamin Ho, Adam R. Aquino, Samuel I. Cockriel, Serah R. Friedman, Bita Kianian, Yinan Lin, Eric R. Malmgren, Brian M.Z. Reece, Simone V. Ward, Derk A. Westermeyer, Suyoung Jang, Show Xiaoyu Wang, Justin E. Culbertson, Jeremiah S. Helm, Hironori Kubota, Paul C. Steinhardt, Kregg A. Koch, Andrew D. Lee, and Yusuke Hirai. Kenneth Wang of KNOBBE, MARTENS, OLSON & BEAR, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      2040 Main Street, 14th Floor
      IRVINE, California 92614
      United States
      858-707-4203(phone)
      9497609502(fax)
      efiling@knobbe.com
The docket/reference number is ACERA.094T.
Kenneth Wang submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Kenneth Wang

PRIMARY EMAIL FOR CORRESPONDENCE: efiling@knobbe.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): 2TYY@knobbe.com; Jennifer.Yi@knobbe.com; 2KKW@knobbe.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Kenneth Wang/   Date: 11/29/2022
Signatory's Name: Kenneth Wang
Signatory's Position: Attorney of record
Signatory's Phone Number: 858-707-4203
Signature method: Signed directly within the form
Payment Sale Number: 97696561
Payment Accounting Date: 11/29/2022

Serial Number: 97696561
Internet Transmission Date: Tue Nov 29 18:48:40 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.XX-2022112918484149
4548-97696561-820f0a4997cb1653398ba2d08b
e11ae45a88dc4bd85dc9a1f57fdfa05a53485a-C
C-48402388-20221129183145747245